342 related articles for article (PubMed ID: 17224260)
1. Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal.
Kinana AD; Cardinale E; Bahsoun I; Tall F; Sire JM; Garin B; Boye CS; Dromigny JA; Perrier-Gros-Claude JD
Int J Antimicrob Agents; 2007 Apr; 29(4):397-401. PubMed ID: 17224260
[TBL] [Abstract][Full Text] [Related]
2. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
Beckmann L; Müller M; Luber P; Schrader C; Bartelt E; Klein G
J Appl Microbiol; 2004; 96(5):1040-7. PubMed ID: 15078520
[TBL] [Abstract][Full Text] [Related]
3. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
McIver C; Hogan T; White P; Tapsall J
Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
[TBL] [Abstract][Full Text] [Related]
4. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
Ge B; McDermott PF; White DG; Meng J
Antimicrob Agents Chemother; 2005 Aug; 49(8):3347-54. PubMed ID: 16048946
[TBL] [Abstract][Full Text] [Related]
5. Campylobacter coli isolates derived from chickens in Senegal: Diversity, genetic exchange with Campylobacter jejuni and quinolone resistance.
Kinana AD; Cardinale E; Bahsoun I; Tall F; Sire JM; Breurec S; Garin B; Saad-Bouh Boye C; Perrier-Gros-Claude JD
Res Microbiol; 2007 Mar; 158(2):138-42. PubMed ID: 17258435
[TBL] [Abstract][Full Text] [Related]
6. Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle.
Jesse TW; Englen MD; Pittenger-Alley LG; Fedorka-Cray PJ
J Appl Microbiol; 2006 Apr; 100(4):682-8. PubMed ID: 16553723
[TBL] [Abstract][Full Text] [Related]
7. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
Bachoual R; Ouabdesselam S; Mory F; Lascols C; Soussy CJ; Tankovic J
Microb Drug Resist; 2001; 7(3):257-61. PubMed ID: 11759087
[TBL] [Abstract][Full Text] [Related]
8. [PCR-restriction fragment length polymorphism assay (PCR-RFLP) as an useful tool for detection of mutation in gyrA gene at 86-THR position associated with fluoroquinolone resistance in Campylobacter jejuni].
Wardak S; Szych J; Cieślik A
Med Dosw Mikrobiol; 2005; 57(3):295-301. PubMed ID: 16494206
[TBL] [Abstract][Full Text] [Related]
9. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
10. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.
Lascols C; Robert J; Cattoir V; Bébéar C; Cavallo JD; Podglajen I; Ploy MC; Bonnet R; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):402-9. PubMed ID: 17254753
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance.
Sonnevend Á; Kovács J; Pál T; Akawi N; Nagelkerke N; Schneider G
Scand J Infect Dis; 2011 Dec; 43(11-12):905-11. PubMed ID: 21905953
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli.
Hänninen ML; Hannula M
J Antimicrob Chemother; 2007 Dec; 60(6):1251-7. PubMed ID: 17911389
[TBL] [Abstract][Full Text] [Related]
13. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
14. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
Pasquali F; Rossi M; Manfreda G; Zanoni R
Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland.
Wardak S; Szych J; Zasada AA; Gierczynski R
Antimicrob Agents Chemother; 2007 Mar; 51(3):1123-5. PubMed ID: 17210776
[TBL] [Abstract][Full Text] [Related]
16. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
17. Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
Pasquali F; Lucchi A; Manfreda G
Int J Antimicrob Agents; 2008 May; 31(5):500-2. PubMed ID: 18329250
[No Abstract] [Full Text] [Related]
18. Antimicrobial resistance profiles and mechanisms of resistance in Campylobacter jejuni isolates from pets.
Acke E; McGill K; Quinn T; Jones BR; Fanning S; Whyte P
Foodborne Pathog Dis; 2009; 6(6):705-10. PubMed ID: 19580444
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
Lee JK; Lee YS; Park YK; Kim BS
Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
